Toshiaki Nishihata
Directeur/Bestuurslid bij RIBOMIC INC.
Profiel
Toshiaki Nishihata is an Independent Outside Director at Ribomic, Inc. and an Outside Director at Trans Chromosomics, Inc. He was previously the President & Chief Executive Officer at Santen, Inc. and the Director, Head-Research & Development Division at Santen Pharmaceutical Co., Ltd.
He also served as a Director at Santen Holdings U.S., Inc. and as a Manager-Pharmaceutical Development Department at Upjohn Pharmaceuticals Ltd.
Actieve functies van Toshiaki Nishihata
| Bedrijven | Functie | Begin |
|---|---|---|
| RIBOMIC INC. | Directeur/Bestuurslid | 01-06-2016 |
Trans Chromosomics, Inc.
 Trans Chromosomics, Inc. Miscellaneous Commercial ServicesCommercial Services Trans Chromosomics, Inc. is a Japanese bio-venture company based on chromosomal engineering technology. The private company, which originated from Tottori University, provides a wide range of TC technology to medical and drug discovery fields, with the aim of contributing to people's lives and health. | Directeur/Bestuurslid | 01-02-2018 |
Eerdere bekende functies van Toshiaki Nishihata
| Bedrijven | Functie | Einde |
|---|---|---|
| Upjohn Pharmaceuticals Ltd. | Corporate Officer/Principal | - |
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | President | - |
Santen Holdings U.S., Inc.
 Santen Holdings U.S., Inc. Financial ConglomeratesFinance Santen Holdings U.S., Inc. operates as holding company. The company is headquartered in Emeryville, CA. | Directeur/Bestuurslid | - |
| SANTEN PHARMACEUTICAL CO., LTD. | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| RIBOMIC INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Health Technology |
Santen Holdings U.S., Inc.
Santen Holdings U.S., Inc. Financial ConglomeratesFinance Santen Holdings U.S., Inc. operates as holding company. The company is headquartered in Emeryville, CA. | Finance |
| Upjohn Pharmaceuticals Ltd. | |
Trans Chromosomics, Inc.
Trans Chromosomics, Inc. Miscellaneous Commercial ServicesCommercial Services Trans Chromosomics, Inc. is a Japanese bio-venture company based on chromosomal engineering technology. The private company, which originated from Tottori University, provides a wide range of TC technology to medical and drug discovery fields, with the aim of contributing to people's lives and health. | Commercial Services |
